2015³âµµ ´ëÇÑÀ̽ÄÇÐȸ Á¦7Â÷ À©ÅͽÉÆ÷Áö¾ö
ÀϽÃ: 2015³â 2¿ù 6ÀÏ(±Ý)-7ÀÏ(Åä)
Àå¼Ò: ±º»ê º£½ºÆ®¿þ½ºÅÏÈ£ÅÚ
2¿ù 6ÀÏ (±Ý) | |
---|---|
08:30-08:50 | µî·Ï |
08:50-09:00 | °³È¸½Ä |
09:00-10:40 | Session I : Practical application of Basic research |
10:40-11:00 | Coffee Break |
11:00-12:20 | Session II: Investigational New drug |
12:20-13:30 | Luncheon Symposium |
13:30-14:10 | Special lecture |
14:10~14:30 | Coffee Break |
14:30~16:30 | Session III : Á¶Á÷±âÁõ°ü·Ã ü°è º¯È¿¡ °üÇÑ °ü¸® ¹× Çù·Â ¹æ¾È¿¡ °üÇÑ ÅäÀÇ |
16:30~18:00 | Poster session |
2¿ù 7ÀÏ (Åä) | |
08:00-10:00 | Donor evaluation and Selection |
2¿ù 6ÀÏ (±Ý) | ||
08:30-08:50 | µî·Ï | |
08:50-09:00 | °³È¸½Ä | ȸÀå: ±èµ¿±¸(°¡Å縯ÀÇ´ë) |
09:00-10:40 | Session I : Practical application of Basic research | ÁÂÀå: ±èµ¿±¸(°¡Å縯ÀÇ´ë), ¾È±Ô¸®(¼¿ïÀÇ´ë) |
09:00-09:20 | Translational Medicine, Changing paradigm | ¾È±Ô¸®(¼¿ïÀÇ´ë) |
09:20-10:00 | ±âÃÊ¿¬±¸¼º°úÀÇ ÇöÀåÀû¿ë ÃËÁøÀ» À§ÇÑ Áß°³¿¬±¸ | ±èº´¼ö(°í·ÁÀÇ´ë) |
10:00-10:40 | How to survive a Korea-born biotech in the Red Oceans of the World? | À±º´¼ö(¿À½ºÆ¼¿À ´º·ÎÁ¨) |
10:40-11:00 | Coffee Break | |
11:00-12:20 | Session II: Investigational New drug | ÁÂÀå: ¹Ú¼º±¤(ÀüºÏÀÇ´ë), ±è¼ºÁÖ(¼º±Õ°üÀÇ´ë) |
11:00-11:40 | JL1, A Novel Therapeutic Target in Acute Leukemia | Á¤°æõ(¼¿ïÀÇ´ë) |
11:40-12:20 | Developing a new drug for selective depletion of alloreactive effector T cells | ¼¼ö±æ(ÀÎÁ¦ÀÇ´ë) |
12:20-13:30 | Luncheon Symposium(¾Æ½ºÅÚ¶ó½º) |
ÁÂÀå: Á¶Àç¿ø(¼º±Õ°üÀÇ´ë), ÃÖµ¿¶ô(°¡Å縯ÀÇ´ë) |
SMART study : A Phase IV, Single center, Open-label, Randomized Study to evaluate the Safety and Efficacy of a Tacrolimus twice daily, PROGRAF® versus a Tacrolimus Modified Release, ADVAGRAF®, in stable Liver transplant recipients taking Tacrolimus twice daily. |
±èÁ¾¸¸(¼º±Õ°üÀÇ´ë) | |
13:30-14:10 | Special lecture | ÁÂÀå: À̼®±¸(¼º±Õ°üÀÇ´ë), ±è¼øÀÏ(¿¬¼¼ÀÇ´ë) |
13:30-14:10 | Current issues in liver transplantation | Yasuhiro Ogura(Nagoya University Hospital) |
14:10-14:30 | Coffee Break | |
14:30-16:30 | Session III : Á¶Á÷±âÁõ°ü·Ã ü°è º¯È¿¡ °üÇÑ °ü¸® ¹× Çù·Â ¹æ¾È¿¡ °üÇÑ ÅäÀÇ | ÁÂÀå: Á¶¿øÇö(°è¸íÀÇ´ë), ±èÇü¼÷(¼¿ï¼º¸ðº´¿ø) |
14:30-15:00 | ÀÎüÁ¶Á÷ ±âÁõ/±¸µæü°è | Á¤¾ç±¹(°¡Å縯ÀÇ´ë) |
15:00-15:30 | Á¶Á÷±âÁõÁö¿ø±â°ü | ÃÖ±Ô¼º(¼º±Õ°üÀÇ´ë) |
15:30-16:00 | Á¶Á÷±âÁõ°ü·Ã ÄÚµð³×ÀÌÅÍÀÇ ¿ªÇÒ | ±èÀοÁ(¼¿ï¾Æ»êº´¿ø) |
16:00-16:30 | Çѱ¹Àå±â±âÁõ¿øÀÇ ¿ªÇÒ | °ÇöÁø(Çѱ¹Àå±â±âÁõ¿ø) |
16:30-18:00 | Poster session | ÁÂÀå: Á¶È«·¡(¿ï»êÀÇ´ë), °øÁø¹Î(BHSÇѼº´¿ø) |
2¿ù 7ÀÏ (Åä) | ||
08:00-10:00 | Donor evaluation and Selection | |
08:00-10:00 | Room A : Kidney Donor Evaluation and Selection Criteria | ÁÂÀå: Á¶¹éȯ(ÀüºÏÀÇ´ë), ±èÀ¯¼±(¿¬¼¼ÀÇ´ë) |
08:00-08:30 | Current improvement of deceased donor management | ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë) |
08:30-09:00 | Selection criteria of marginal donors and their recipients | ¿ÀÁؼ®(ºÀ»ýº´¿ø) |
09:00-09:30 | Dual kidney transplantation | ±èÇüÅÂ(°è¸íÀÇ´ë) |
09:30-10:00 | Panel discussion | |
08:00-10:00 | Room B : Living Liver Donor Evaluation and Selection Criteria | ÁÂÀå: ¼°æ¼®(¼¿ïÀÇ´ë), ³ª¾ç¿ø(¿ï»êÀÇ´ë) |
08:00-08:15 | Living Liver Donor Evaluation and Selection Criteria: Right Liver Graft- Remnant Volume over 30% |
À̳²ÁØ(¼¿ïÀÇ´ë) |
08:15-08:30 | Right lobe graft-Remnant volume less than 30% | À̽´ö(±¹¸³¾Ï¼¾ÅÍ) |
08:30-09:00 | Paradigm shift in the adult living donor liver transplantation between the left liver and the right liver | Yasuhiro Ogura(Nagoya University Hospital) |
09:00-09:30 | Living Liver Donor Evaluation and Selection Criteria: Right Posterior Sector Graft |
±èºÀ¿Ï(¾ÆÁÖÀÇ´ë) |
09:30-10:00 | ABO incompatable liver transplantation | ¼Û±â¿ø(¿ï»êÀÇ´ë) |